Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension
- PMID: 29673911
- DOI: 10.1016/j.pupt.2018.04.004
Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension
Abstract
Background: Hypoxic pulmonary arterial hypertension (PAH) is a crippling disease with limited therapeutic methods. The imbalance of T helper 17 cell (Th17)/regulatory T cell (Treg) plays an important role in the development of Hypoxic PAH. However, whether targeting the ras homolog family member A-Rho kinase (RhoA-ROCK) pathway (activation and inhibition) by lysophosphatidic acid (LPA) and fasudil (FSD) regulate T-cell homeostasis in Hypoxic PAH remain unknown.
Objective: To examine the effects of LPA and FSD on hypoxic pulmonary vascular remodeling and homeostasis of Th17/Treg cells in Hypoxic PAH.
Methods: Rats were exposed to hypoxia (10 ± 0.5% O2) to induce Hypoxic PAH. The experiments consists of two parts. Forty rats were randomly divided into four groups (n = 10): normoxia group, normoxia + LPA group, hypoxia group and hypoxia + LPA group. Thirty rats were randomly divided into another three groups (n = 10): normoxia group, hypoxia group, and hypoxia + FSD group. Rats in normoxia + LPA group and hypoxia + LPA group were intraperitoneally injected 40 μg/kg LPA daily. Rats in hypoxia + FSD group were intraperitoneally injected 30 mg/kg fasudil daily. The effects of LPA and FSD on the development of hypoxic PAH and right ventricle (RV) hypertrophy, on pulmonary vascular remodeling, and on changes of Th17/Treg cells and levels of interleukin-17 (IL-17) and IL-10 were examined.
Results: PAH and RV hypertrophy occurred in rats exposed to hypoxia. LPA exacerbated hypoxic pulmonary vascular remodeling and FSD inhibited it. LPA increased Th17/Treg imbalance in peripheral blood and spleen. However, after treatment with FSD, hypoxic PAH rats showed an obvious reduction of Th17 cells as well as an increase of Treg cells. LPA increased the expression of phosphorylated-signal transducer and activator of transcription 3 (p-STAT3) and reduced the p-STAT5 in peripheral blood and spleen in hypoxic PAH rats. The expression of p-STAT3 and p-STAT5 in hypoxic PAH rats treated with FSD showed opposite changes. LPA increased the expression of IL-17 and reduced the IL-10 in small intrapulmonary arteries and serum in hypoxic PAH. However, the expression of IL-17 and IL-10 in hypoxic PAH rats treated with FSD showed opposite changes.
Conclusions: Activation and inhibition of RhoA-ROCK pathway by LPA and FSD modulated the homeostasis of Th17/Treg cells via regulating STAT3/STAT5 phosphorylation in hypoxic PAH. Thus, Apart from influence of pulmonary vascular remodeling, regulation of Th17/Treg homeostasis by RhoA-ROCK pathway play a key role in hypoxic PAH.
Keywords: Fasudil; Hypoxic pulmonary arterial hypertension; Lysophosphatidic acid; Regulatory T cell; T helper 17 cell.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Baicalin suppresses Th1 and Th17 responses and promotes Treg response to ameliorate sepsis-associated pancreatic injury via the RhoA-ROCK pathway.Int Immunopharmacol. 2020 Sep;86:106685. doi: 10.1016/j.intimp.2020.106685. Epub 2020 Jun 20. Int Immunopharmacol. 2020. PMID: 32570032
-
LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H377-H391. doi: 10.1152/ajpheart.00717.2019. Epub 2020 Jun 19. Am J Physiol Heart Circ Physiol. 2020. PMID: 32559140
-
Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.Toxicol Appl Pharmacol. 2019 Apr 15;369:60-72. doi: 10.1016/j.taap.2019.02.017. Epub 2019 Mar 1. Toxicol Appl Pharmacol. 2019. PMID: 30831131
-
Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.Recent Pat Cardiovasc Drug Discov. 2012 Aug;7(2):100-4. doi: 10.2174/157489012801227238. Recent Pat Cardiovasc Drug Discov. 2012. PMID: 22670803 Review.
-
Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.Expert Opin Ther Targets. 2012 Apr;16(4):355-63. doi: 10.1517/14728222.2012.671811. Epub 2012 Mar 27. Expert Opin Ther Targets. 2012. PMID: 22449260 Review.
Cited by
-
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling.Br J Pharmacol. 2021 Jan;178(1):187-202. doi: 10.1111/bph.14945. Epub 2020 Feb 4. Br J Pharmacol. 2021. PMID: 31793661 Free PMC article.
-
Cardioprotection in right heart failure.Br J Pharmacol. 2020 Dec;177(23):5413-5431. doi: 10.1111/bph.14992. Epub 2020 Mar 9. Br J Pharmacol. 2020. PMID: 31995639 Free PMC article. Review.
-
LPG 18:0 is a general biomarker of asthma and inhibits the differentiation and function of regulatory T-cells.Eur Respir J. 2024 Dec 5;64(6):2301752. doi: 10.1183/13993003.01752-2023. Print 2024 Dec. Eur Respir J. 2024. PMID: 39147414 Free PMC article.
-
ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.Cells. 2021 Jun 30;10(7):1648. doi: 10.3390/cells10071648. Cells. 2021. PMID: 34209333 Free PMC article. Review.
-
Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension.Apoptosis. 2023 Apr;28(3-4):432-446. doi: 10.1007/s10495-022-01797-y. Epub 2022 Dec 9. Apoptosis. 2023. PMID: 36484960
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
